We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

603501:SSEOmniVision Integrated Circuits Group, Inc. Class A Analysis

Data as of 2026-09-13 - not real-time

CN¥76.88

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind OmniVision Integrated Circuits Group, Inc. is bearish at ¥76.88, with short-term averages lagging the long-term ones. The last 30 days have lost 13.3%. Momentum indicators put RSI at 30.4 (approaching oversold) with MACD reading bearish. Recent trading has carved out support near ¥76.10 and resistance around ¥92.17.
Multiples put this in undervalued territory: 29.0 times earnings against the sector's 33.2. Consensus targets land 53.7% above where the shares trade now. The 0.94% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 32.7%, a beta of 0.44 and a maximum drawdown of 49.1%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 3/10 conviction on the long call.

Top Market Events

Latest OmniVision Integrated Circuits Group Inc 603501:SHH.Investing2monOmniVision Integrated Circuits Group IncWe've identified the following companies as similar to OmniVision...Latest OmniVision Integrated Circuits Group Inc 501:HKG share price with interactive charts, historical prices,...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 105.02
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 29.0 versus sector average of 33.2
  • Trading below the 200-day average of 105.02

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 29.0 versus sector average of 33.2
  • Analyst targets imply +53.7% versus the current price
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth1.70%
Profit Margin11.19%
P/E Ratio29.0
ROE10.92%
ROA5.45%
Debt/Equity35.45
P/B Ratio2.9
Op. Cash FlowCN¥2.6B
Free Cash FlowCN¥-567397760
Industry P/E33.2

Technical Analysis

TrendBearish
RSI30.4
SupportCN¥76.10
ResistanceCN¥92.17
MA 20CN¥83.18
MA 50CN¥91.23
MA 200CN¥105.02
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14

Valuation

Fair ValueCN¥22.71
Target PriceCN¥118.18
Upside/Downside53.72%
GradeUndervalued
TypeBlend
Dividend Yield0.94%

Risk Assessment

Beta0.44
Volatility32.74%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.